EIF2AK2

Chr 2ADAR

eukaryotic translation initiation factor 2 alpha kinase 2

Also known as: PKR, PPP1R83, PRKR

The protein encoded by this gene is a serine/threonine protein kinase that is activated by autophosphorylation after binding to dsRNA. The activated form of the encoded protein can phosphorylate translation initiation factor EIF2S1, which in turn inhibits protein synthesis. This protein is also activated by manganese ions and heparin. The encoded protein plays an important role in the innate immune response against multiple DNA and RNA viruses. [provided by RefSeq, Jul 2021]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismAD/ARLOEUF 0.522 OMIM phenotypes
Clinical SummaryEIF2AK2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.30) despite low pLI — interpret in context.
📋
ClinVar Variants
5 unique Pathogenic / Likely Pathogenic· 151 VUS of 272 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — EIF2AK2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.52LOEUF
pLI 0.018
Z-score 3.61
OE 0.30 (0.180.52)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.28Z-score
OE missense 0.79 (0.700.88)
222 obs / 282.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.30 (0.180.52)
00.351.4
Missense OE?0.79 (0.700.88)
00.61.4
Synonymous OE?1.05
01.21.6
LoF obs/exp: 9 / 30.5Missense obs/exp: 222 / 282.3Syn Z: -0.37
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongEIF2AK2-related developmental delay, leukoencephalopathy, and neurologic decompensationOTHERAD

This gene — mechanism propensity

DN
0.86top 5%
GOF
0.83top 10%
LOF
0.1796th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median · 1 literature citation
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNTherefore, given that EIF2AK1 and EIF2AK2 require dimerization to phosphorylate their downstream target, the most likely pathogenic mechanism of the de novo missense variants are dominant-negative mutations affecting the function of the wild-type protein.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 32197074

ClinVar Variant Classifications

272 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic4
VUS151
Likely Benign74
Benign14
Conflicting9
1
Pathogenic
4
Likely Pathogenic
151
VUS
74
Likely Benign
14
Benign
9
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
0
0
0
1
Likely Pathogenic
1
3
0
0
4
VUS
12
128
7
4
151
Likely Benign
1
18
25
30
74
Benign
0
2
6
6
14
Conflicting
9
Total151513840253

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

17 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap EIF2AK2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

EIF2AK2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.